ALAYNA VANWINKLE: Open Payments
NPI 1598461428 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,772 in 200 payments from 33 companies in 2025. Trend: 2023 $53 · 2024 $2,937 · 2025 $3,772
Food & beverage: $3,772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $663 |
| Madrigal Pharmaceuticals | 10 | $423 |
| Novo Nordisk Inc | 22 | $380 |
| Amgen Inc. | 20 | $267 |
| Antares Pharma, Inc. | 13 | $252 |
| PFIZER INC. | 12 | $221 |
| AstraZeneca Pharmaceuticals LP | 4 | $209 |
| Lundbeck LLC | 12 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $129 |
| GlaxoSmithKline, LLC. | 6 | $110 |
Products named: REZDIFFRA, VRAYLAR, XYOSTED, AIRSUPRA, QULIPTA, Ozempic, REXULTI, OTEZLA.
Industry payments across AZ — which companies pay providers there.
